Pluri Inc. — Capital/Financing Update 2007

Nov 26, 2007

8-K 1 v095541_8k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 26, 2007

| PLURISTEM

THERAPEUTICS INC.
(Exact
name of registrant as specified in its
charter)

NEVADA	001-31392	98-0351734
(State
or other jurisdiction	(Commission	(IRS
Employer
of
incorporation)	File
Number)	Identification
No.)

| MATAM

Advanced Technology Park, Building No. 20, Haifa, Israel	31905
(Address
of principal executive offices)	(Zip
Code)

+972-74-710-7171

(Registrant’s telephone number, including area code)

| PLURISTEM

LIFE SYSTEMS, INC.
(Former
name or former address, if changed since last
report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01 Other Events.

On November 26, 2007, the registrant issued a press release announcing the effectiveness of its reverse stock split and change of name to Pluristem Therapeutics Inc., as well as its new trading symbol. A copy of the Press Release is attached hereto as Exhibit 99.1 and incorporated by reference herein .

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

99.1 Press release issued by the registrant on November 26, 2007

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

| | PLURISTEM THERAPEUTICS INC. (registrant) | | --- | --- | | By: | /s/ Zami Aberman | | Date: November 26, 2007 | | | | Name: Zami Aberman Title: Chief Executive Officer |